Abstract
BackgroundGliomas are recalcitrant brain tumors. Anti-glioma immunity and immunopathogenic responses are critical contributors for better survival of isocitrate dehydrogenase-mutant (IDHmut) over wild-type (IDHwt) gliomas. Despite this correlative pattern of immunity...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have